11 Best Marijuana Stocks To Buy Now

Published on May 27, 2023 at 5:24 pm by Hamna Asim in Hedge Funds, News

In this article, we discuss 11 best marijuana stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Marijuana Stocks To Buy Now.

Previously, we reported that in 2022, the cannabis industry had a mixed performance, with some new markets experiencing growth while sales declined in established markets. COVID-19 played a role in this, leading to challenges such as job cuts and increased debt for many companies. However, there were positive developments as well, including more states legalizing adult-use cannabis and federal progress in reform efforts. Legal retailers faced difficulties with taxes, regulations, and competition from the illegal market, which are likely to continue in 2023. Despite these challenges, the growth rate of legal cannabis sales in the United States is expected to maintain a double-digit annual compound growth rate, even without federal legalization.

As per Hub International, the cannabis industry continues to face obstacles in achieving profitability. Challenges such as disruptions in the supply chain, product recalls, regulatory issues, and economic difficulties persist, making it crucial for comprehensive risk management strategies to mitigate the impact of these exposures. The industry is grappling with rising inflation and increased costs for essential resources like fertilizer, building materials, and packaging, which are negatively impacting its financial performance. However, cannabis companies are hesitant to raise prices in an intensely competitive market. Furthermore, the industry is confronted with high taxes and barriers to interstate commerce, posing ongoing challenges. In the first half of 2022, over 20 of the largest publicly traded cannabis companies experienced losses of approximately $550 million, despite generating revenues of nearly $4.5 billion.

However, the acceptance and normalization of cannabis are gradually increasing, with each mainstream reference and recognition contributing to the erosion of opposition towards federal legalization. While political predictions may vary, the normalization of cannabis presents a significant opportunity for operators, brands, and markets to expand their presence in 2023.

According to Cannabis Business Times, Missouri is set to transition from a medical cannabis market to an adult-use market within a short period of three months after passing a ballot initiative. The state’s active participation in the medical market, coupled with a low consumer tax rate, positions Missouri as an important state to monitor in 2023. In Minnesota, the legalization of edibles and beverages containing 5 mg of THC or less took place in 2022. This has led to the widespread availability of delivery services and on-premise consumption of THC-infused beverages in a state with a population of approximately 5.7 million. The recent election results, where Democrats secured control over the governorship, the Senate, and the House, have created a favorable political climate for cannabis. Notably, draft legislation for adult-use cannabis has already been unveiled, emphasizing its priority during the current legislative session.

To benefit from the growing opportunities in the cannabis industry, some of the best stocks to buy include Jazz Pharmaceuticals plc (NASDAQ:JAZZ), The Scotts Miracle-Gro Company (NYSE:SMG), and Tilray Brands, Inc. (NASDAQ:TLRY).

Our Methodology

We selected the following marijuana stocks based on the hedge fund sentiment toward each stock. We have assessed the hedge fund sentiment from Insider Monkey’s database of 943 elite hedge funds tracked as of the end of the first quarter of 2023. The list is arranged in ascending order of the number of hedge fund holders in each firm.

Photo by terre-di-cannabis on Unsplash

Best Marijuana Stocks To Buy Now

11. Organigram Holdings Inc. (NASDAQ:OGI)

Number of Hedge Fund Holders: 5

Organigram Holdings Inc. (NASDAQ:OGI) is involved in the manufacturing and distribution of cannabis and cannabis-related items within Canada. The company provides a range of medical cannabis products, such as cannabis flowers, gummies, oils, and vaporizers, catering to both civilian patients and veterans. They also offer recreational cannabis for adult use.

On April 13, Canaccord analyst Matt Bottomley maintained a Speculative Buy rating on Organigram Holdings Inc. (NASDAQ:OGI) but lowered the firm’s price target on the shares to C$2.25 from C$3.25.

According to Insider Monkey’s first quarter database, 5 hedge funds held stakes worth $2.21 million in Organigram Holdings Inc. (NASDAQ:OGI), compared to 7 funds in the prior quarter worth $2.96 million. D E Shaw held the biggest stake in the company, comprising 1.4 million shares valued at $910,775.

Like Jazz Pharmaceuticals plc (NASDAQ:JAZZ), The Scotts Miracle-Gro Company (NYSE:SMG), and Tilray Brands, Inc. (NASDAQ:TLRY), Organigram Holdings Inc. (NASDAQ:OGI) is one of the best marijuana stocks to invest in.

10. Leafly Holdings, Inc. (NASDAQ:LFLY)

Number of Hedge Fund Holders: 6

Leafly Holdings, Inc. (NASDAQ:LFLY) owns and operates an online platform connecting consumers with cannabis brands and licensed retailers. Through its website and mobile applications, Leafly Holdings, Inc. (NASDAQ:LFLY) offers information, reviews, menus, and options for ordering and delivery to its audience.

On May 11, Leafly Holdings, Inc. (NASDAQ:LFLY) reported a Q1 GAAP EPS of -$0.14 and a revenue of $11.2 million, outperforming Wall Street estimates by $0.03 and $0.09 million, respectively.

Benchmark analyst Daniel Kurnos maintained a Buy rating on Leafly Holdings, Inc. (NASDAQ:LFLY) but trimmed the firm’s price target on the shares from $12.00 to $6.50 on December 8, 2022. While Leafly Holdings, Inc. (NASDAQ:LFLY) did not perform well in the first half of 2022, the analyst noted that there were still potential opportunities for growth in the second half of the year. These include leveraging their industry-leading content portfolio and international capabilities for additional monetization, as well as the possibility of regulatory relief, particularly in major East Coast cities.

According to Insider Monkey’s first quarter database, 6 hedge funds were long Leafly Holdings, Inc. (NASDAQ:LFLY), compared to 7 funds in the preceding quarter.

9. Canopy Growth Corporation (NASDAQ:CGC)

Number of Hedge Fund Holders: 7

Canopy Growth Corporation (NASDAQ:CGC) specializes in the manufacturing, distribution, and retail of cannabis and hemp-derived products for both recreational and medical use. Their operations primarily focus on Canada, the United States, and Germany. The company’s product range includes dried cannabis flower, extracts, concentrates, beverages, gummies, and vaporizers.

On April 14, Canopy Growth Corporation (NASDAQ:CGC) revealed its plans to refinance C$100 million of its outstanding 4.25% unsecured notes, which are set to mature in 2023. The company has entered into an exchange agreement with Greenstar Canada Investment Limited Partnership, a wholly-owned subsidiary of Constellation Brands. Through this agreement, Canopy Growth Corporation (NASDAQ:CGC) aims to eliminate C$100 million of its existing notes.

According to Insider Monkey’s first quarter database, 7 hedge funds were bullish on Canopy Growth Corporation (NASDAQ:CGC), compared to 11 funds in the earlier quarter. Lee Ainslie’s Maverick Capital is a prominent stakeholder of the company, with 221,848 shares worth $388,234.

8. Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM)

Number of Hedge Fund Holders: 7

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) engages in the production and distribution of equipment and supplies for controlled environment agriculture in the United States and Canada. The company offers a range of agricultural lighting devices, equipment for indoor climate control, nutrients, and plant additives. These products are utilized for growing and cultivating various crops, including cannabis, flowers, fruits, plants, vegetables, grains, and herbs within controlled environments. It is one of the best marijuana stocks to invest in.

In response to Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM)’s Q1 results, Stifel analyst W. Andrew Carter adjusted the firm’s price target on the stock from $1.80 to $1.45 while maintaining a Hold rating on May 11. Stifel has a mixed perspective on the company, considering the narrower EBITDA loss as a positive, but remaining cautious due to the conservative outlook provided for revenue guidance. With uncertainties surrounding the timing and extent of Hydrofarm’s recovery, Stifel believes a neutral stance on the stock is warranted.

According to Insider Monkey’s first quarter database, 7 hedge funds were bullish on Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM), compared to 10 funds in the prior quarter. Michael Zimmerman’s Prentice Capital Management is the biggest position holder in the company, with 518,852 shares worth $897,614.

Here is what Baron Discovery Fund has to say about Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) in its Q4 2021 investor letter:

“Our top 10 holdings represented 25.6% of the Fund’s net assets at the end of the fourth quarter. This is in line with historical weightings. Cash at the end of the quarter was 3.4%, which is in line with our low to mid-single digit targeted levels. We exited our position in Hydrofarm Holdings Group, Inc. as we felt the macro headwinds the company was facing in its end-markets were both challenging and worsening.”

7. Cronos Group Inc. (NASDAQ:CRON)

Number of Hedge Fund Holders: 8

Cronos Group Inc. (NASDAQ:CRON) is a cannabinoid company that engages in the production, marketing, and distribution of hemp-derived supplements and cosmetic products in the United States. Additionally, Cronos Group Inc. (NASDAQ:CRON) is actively involved in the cultivation, manufacturing, and marketing of cannabis and cannabis-derived products for both medical and adult-use markets. Their product range includes dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts. It is one of the best marijuana stocks to watch.

On May 15, following Cronos Group Inc. (NASDAQ:CRON)’s Q1 results, Barclays analyst Gaurav Jain maintained an Equal Weight rating on the company’s shares but decreased the firm’s price target from $3.50 to $3. Jain attributed the adjustment to the challenging conditions within the industry and a less favorable macroeconomic environment, which have contributed to a more uncertain outlook for the company.

According to Insider Monkey’s first quarter database, 8 hedge funds were long Cronos Group Inc. (NASDAQ:CRON), compared to 7 funds in the last quarter. D E Shaw held the biggest stake in the company, comprising 1.95 million shares worth $3.7 million.

6. Aurora Cannabis Inc. (NASDAQ:ACB)

Number of Hedge Fund Holders: 8

Aurora Cannabis Inc. (NASDAQ:ACB) specializes in the production, distribution, and sale of cannabis and cannabis-derived products within Canada and internationally. The company focuses on both medical and consumer cannabis products within the Canadian market.

Aurora Cannabis (NASDAQ:ACB) announced on April 24 that it has bought back approximately $16.6 million worth of its convertible senior notes through multiple transactions since April. This move has allowed the company to save $1.9 million in annual interest payments. Once these repurchases are finalized, Aurora Cannabis (NASDAQ:ACB) will have approximately $59 million in outstanding notes. The purpose of these transactions is to lower the company’s debt and decrease its annual cash interest expenses. In fact, Aurora Cannabis (NASDAQ:ACB) has repurchased around $286 million of its convertible senior notes since December 2021, resulting in annual savings of approximately $16 million in cash interest.

According to Insider Monkey’s first quarter database, 8 hedge funds were bullish on Aurora Cannabis (NASDAQ:ACB), compared to 9 funds in the prior quarter. Anand Parekh’s Alyeska Investment Group is a significant position holder in the company, with 820,000 shares worth $571,786.

In addition to Jazz Pharmaceuticals plc (NASDAQ:JAZZ), The Scotts Miracle-Gro Company (NYSE:SMG), and Tilray Brands, Inc. (NASDAQ:TLRY), Aurora Cannabis (NASDAQ:ACB) is one of the premier marijuana stocks to buy.

Click to continue reading and see 5 Best Marijuana Stocks To Buy Now.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on December 13, 2024 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

China’s terrifying internet “Master Key”… and the one microcap that could stop them

Published on December 18, 2024 at by Insider Monkey Staff

In August 2024, news outlets around the world revealed one of the most shocking data breaches in recent history.

Approximately 2.9 billion records, including names, email addresses, phone numbers, mailing addresses, financial data and, distressingly, Social Security numbers, were stolen when Coral Springs, Florida, firm National Public Data (NPD) suffered a massive cyberattack. The company confirmed that the breach, which happened in December 2023, resulted in the potential leaks of data in the summer of 2024.

Nearly every day in the news, we hear about yet another damaging data breach or ransomware attack that puts valuable data — including yours — into the hands of hackers. And the number of attacks is soaring — up 30% year over year according to the latest numbers.

As bad as this is, it’s a day at the beach compared to what’s coming.

That’s because hostile nations across the globe — including Iran, North Korea, Russia and Communist China are going all-out to develop a breakthrough technology that will unlock what I call the “Master Key” to the Internet.

If they succeed in harnessing this groundbreaking “Master Key” technology, the consequences could be catastrophic.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up